Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Researchers see future cure for eye cancer
The St Jude investigators discovered that, in mice, the p107 gene is active before birth in the cells that are fated to produce the mature retina. This gene
The St Jude investigators discovered that, in mice, the p107 gene is active before birth in the cells that are fated to produce the mature retina. This gene
Abbokinase is the trade name for urokinase, an enzyme produced by human kidneys to lyse (dissolve) blood clots. Abbokinase is approved for the lysis of acute massive pulmonary
The research is partially funded by a US National Institutes of Health (NIH) grant from the National Institute of General Medical Sciences and the recent findings were published
Cytogen expects to begin the first US phase I clinical trial of CYT-500 in patients with hormone-refractory prostate cancer subject to institutional review board approval at the planned
The approval for the three abbreviated new drug applications (ANDAs) broadens Accentia’s pain product portfolio, especially for chronic pain indications. Teamm Pharmaceuticals, Accentia’s wholly owned specialty pharmaceutical subsidiary,
Sirtex’ SIR-Spheres microspheres are the only FDA-approved radioactive microspheres for the treatment of metastatic liver tumors. Xeloda (capecitabine), meanwhile, is the only FDA-approved oral chemotherapy for metastatic breast
Based on results from the trial, Mission Pharmacal plans to file a supplemental new drug application (sNDA) with the FDA for the use of Tindamax (tinidazole) as a
Bronchial thermoplasty, a minimally invasive procedure, uses Asthmatx’ Alair system to deliver heat to the airway walls to reduce the presence of airway smooth muscle, the tissue responsible
In its research efforts with S2, GEN ID is seeking to develop yet another class of compounds to counteract the resistance that H5N1 is acquiring through mutations. The
The first step of the cooperation will consist of a feasibility test for the manufacturing of the drug, an infusion-administered alpha 1-proteinase inhibitor (API), from the European company’s